// App-Quantinova.ai

: BETTING ON PRC2 ALTERATION IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Guillaume Andrieu

Principal Investigators

  • Milena Kohn

  • Charlotte Smith

  • Aurlie Le Nezet

  • Mathieu Simonin

  • Carlos Graux

  • Stphane Leprtre

  • Franoise Huguet

  • Vronique Lhritier

  • Herv Dombret

  • Nicolas Boissel

  • Salvatore Spicuglia

  • Elizabeth Macintyre

  • Vahid Asnafi

Medical Centers

  • Team 2 - Immunology, Infectiology and Haematology Department,Institut Necker Enfants-Malades,Paris,France

  • Laboratory of Onco-Hematology,Institut Necker-Enfants Malades,Paris,France

  • Team 2 - Immunology, Infectiology and Haematology Department,Institut Necker Enfants-Malades,Paris,France

  • Godinne University Hospital ,Louvain,Belgium

  • Centre Henri Becquerel and Université de Rouen Normandie,Rouen,France

  • Institut Universitaire du Cancer de Toulouse, Toulouse, France

  • Lyon Sud Hospital, Lyon, France

  • Aphp Saint-Louis Hospital, Paris, France

  • TAGC,Marseille,France

  • Laboratory of Onco-Hematology,Institut Necker-Enfants Malades,Paris,France

  • Team 2 - Immunology, Infectiology and Haematology Department,Institut Necker Enfants-Malades,Paris,France

Locations

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Polycomb repressive complex 2

  • Embryonic ectoderm development

  • Enhancer of zeste homolog 2

Drug/Treatment

  • EZH2

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved